Psychologists in Allentown, NJ Accepting Medicare
4 Psychologists found. Showing 1 - 4
 Dr. Scott Spreat, ED.D. Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 3 Imlaystown Hightstown Rd, Allentown, NJ 08501 Phone: 609-223-2203 Fax: 609-223-2204 |
 Dr. Laura Tahir, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3 S Main St # 694, Allentown, NJ 08501 Phone: 609-443-3828 |
Dr. Chester Sigafoos, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 235 Province Line Rd, Allentown, NJ 08501 Phone: 609-758-2471 |
Dr. Kenneth Harold Vaughan, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3 South Main Street, Suite #6, Allentown, NJ 08501 Phone: 609-259-6200 Fax: 609-259-6288 |
News Archive
New study on rural HIV shows significant stigma and discrimination in the rural medical referral system
An Indiana University study found that HIV care providers in rural Indiana report significant stigma and discrimination in the rural medical referral system surrounding issues of HIV and substance abuse. Providers felt that these factors impeded their ability to offer quality care to their patients.
SARS-CoV-2 was in NYC a good month before it was first identified, say researchers
Researchers at Icahn School of Medicine at Mount Sinai in New York have provided evidence suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – was infecting people in New York City (NYC) at least one month before the first case was officially documented in the city.
Discrimination associated with compromised sleep quality in adolescents
In a Child Development study of daily diary descriptions of discrimination by minority adolescents, experiencing discrimination during the day was associated with compromised sleep quality that night, as well as feelings of greater daytime dysfunction and sleepiness the following day.
Neoprobe submits IND amendment to FDA for RIGScan CR radiopharmaceutical
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
› Verified 9 days ago
Counselors
Clinical Social Workers
Psychologists
Pharmacists
Dentists
Occupational Therapists